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Definition
               Since   1995,   according   to   the   World   Health   Organisation’s   classification   of 
cardiomyopathies, Naxos disease has been considered as the recessive form of arrhythmogenic 
right  ventricular   dysplasia/cardiomyopathy   (ARVD/C).1  It   is   a   stereotype   association   of 
ARVD/C   with   a   cutaneous   phenotype,   characterised   by   woolly   hair   and   palmoplantar 
keratoderma.2 
Epidemiology
            Naxos disease was first reported in 1986 by Protonotarios et al in patients originating 
from the Hellenic island of Naxos.2,3 Apart from Naxos, cases have also been reported from 
other Hellenic islands, as well as from Turkey, Israel and Saudi Arabia.4 The prevalence of the 
disease in Hellenic islands reaches 1:1000. A variety of Naxos disease presenting at a younger 
age with more pronounced left ventricular involvement has been described in families from 
India and Ecuador (Carvajal syndrome).5,6                                                                                            
Molecular Genetics                                                                                       
 
            Genetic studies have located two causative genes, encoding for the proteins plakoglobin 
and   desmoplakin.   Plakoglobin   and   desmoplakin   are   proteins   of   cell-cell   adhesion.
        A 2-base-pair deletion mutation of the plakoglobin gene (Pk2157del2TG) truncating the C-
terminal of the protein causes Naxos disease.7 This mutation was identified in 13 families from 
Greece and in one family from Turkey.4,8 The prevalence of heterozygous carriers is up to 5% of 
the Naxos population (20,000 inhabitants). Heterozygotes present normal phenotype except in a 
small minority who show woolly hair as well as a few electrocardiographic or echocardiographic 
abnormalities not fulfilling the criteria for ARVC.9 Two different mutations of the desmoplakin 
gene (Dsp7901del1G and DspG2375R), truncating the C-terminal of the protein, have been 
found to underlie a similar cardiocutaneous syndrome in families from Ecuador and Israel.10,11    
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Clinical presentation and natural history                                                                           
 
            In patients with Naxos disease woolly hair was apparent from birth (Figure 1A), whereas 
palmoplantar keratoderma developed during the first year of life as soon as the infant started to 
use the hands and feet (Figures 1B and 1C).9,12 In childhood the patients were asymptomatic 
with no diagnostic cardiac findings. During adolescence all affected members presented 
electrocardiographic and/or echocardiographic abnormalities fulfilling the criteria for ARVC.13 
Resting   12-lead   electrocardiogram   was   abnormal   in   more   than   90%   of   patients.9 
Electrocardiographic abnormalities included inverted T waves in leads V1 to V3 or across the 
precordial leads (77%), QRS complex prolongation in leads V1 to V3 (73%), epsilon waves 
(42%) (Figure 1E) and complete or incomplete right bundle branch block (35%).9 Low voltage 
and/or flat T waves in left precordial leads were mostly observed in severe right or biventricular 
involvement. Ventricular extrasystoles of left bundle branch block configuration were recorded 
in the majority of patients. Ventricular extrasystoles of right bundle branch block configuration 
were less common. All patients presented right ventricular structural/functional alterations; 
minor alterations, consisting of mild dilatation or regional hypokinesia, were detected in 27% 
while major, consisting of severe dilatation, diffuse hypokinesia and aneurysms mostly of the 
outflow tract, apex or inferior wall, were detected in 73% of patients.9 In one fourth of patients 
left ventricular abnormalities ranging from regional hypokinesia particularly of posterior wall or 
apex   to   diffuse   dilatation   and   global   hypokinesia   were   detected.9
            The symptomatic presentation was usually with syncope and/or sustained ventricular 
tachycardia during adolescence with a peak in young adulthood.14 During follow-up arrhythmic 
events occurred in half of the patients.9 The ECG during ventricular tachycardia always showed 
a left bundle branch block pattern (Figure 1F) with a frontal plane axis ranging from -30 to -60 
degrees or +60 to +165 degrees.  14  The inducibility of sustained monomorphic ventricular 
tachycardia in the electrophysiology laboratory was high among those presenting with a clinical 
episode. Heart disease progressed during time to the right or both ventricles. Congestive heart 
failure developed in one fourth of patients at the end stage of severe right or biventricular 
involvement.
        The annual total cardiac mortality rate was 3% and the annual sudden death mortality rate 
reached 2.3%.9 Syncope, left ventricular involvement and the appearance of symptoms and/or 
structural progression before the age of 35 years were risk factors for sudden death.9 
        Cardiac histology revealed the typical pattern of ARVD/C15 with fibrofatty replacement of 
right ventricular myocardium mainly in subepicardial and mediomural layers being regionally 
transmural with formation of aneurysms.4,16  Surviving myocytes surrounded by fibrosis were 
embedded within fatty tissue (Figure 1D). Involved left ventricular myocardium showed 
fibrofatty or fibrous replacement.4 Lymphocyte infiltrates were observed particularly when the 
biopsy was performed at the time of clinical progression. Cardiac histology in one patient from 
Ecuador with the Carvajal variant of Naxos disease differed only in that the fatty component of 
replacement process was absent.17 Immunohistochemical studies, showed that the signal of the 
mutated protein (plakoglobin or desmoplakin) and the signal of connexin43 were diminished at 
intercellular junctions.17,18
Pathogenesis of ARVD/C in Naxos disease                                                                     
               Myocardial cells are differentiated bipolar cells coupled at intercalated discs where 
adherence junctions, desmosomes and gap junctions are located.19  Adherence junctions and 
desmosomes   secure   mechanical   coupling   while   gap   junctions   serve   electrical   coupling. 
Plakoglobin (γ-catenin) is the only known common component of both adherence junctions and 
desmosomes functioning also as a signaling molecule apart from its structural role in securing 
the intercellular adhesion.20 At the adherence junctions it is connected to the actin cytoskeleton 
and at desmosomes to the intermediate filaments of desmin. Desmoplakin is also a cytoplasmic 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 5(2): 76-80 (2005)Nikos Protonotarios and Adalena Tsatsopoulou, “Naxos Disease”                                        78
protein of the desmosomes that interlinks plakoglobin or plakophilin with desmin intermediate 
filaments. Defects in linking sites of these proteins can interrupt the contiguous chain of cell 
adhesion, particularly under conditions of increased mechanical stress or stretch, leading to cell 
isolation and death, progressive loss of myocardium and fibro-fatty replacement.4,7 The degree 
of participation of fat in the repair process may be related to the rate of disease progression or 
may be mutation specific.4 Surviving myocardial fibers within fibro-fatty tissue provide a slow 
conduction substrate inducing re-entrant ventricular arrhythmias.21  Recent studies on Naxos 
disease revealed that the genetically determined defect in cell adhesion results in early gap 
junctions remodeling and altered electrical coupling which may act synergically with the 
progressive  pathologic  changes   in  myocardium   contributing  to  a  highly  arrhythmogenic 
substrate.18 
Figure 1: Naxos disease phenotype of the skin and heart. Woolly hair (A) and palmoplantar 
keratoderma (B and C) are the principal cutaneous abnormalities. The disease is expressed in the 
heart as arrhythmogenic right ventricular dysplasia. Myocardial loss and fibrofatty replacement 
of right ventricular myocardium (D) results in delayed activation (epsilon waves on surface 
ECG) (E) predisposing to reentrant ventricular arrhythmias (F). 
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